Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2− Breast Cancer-Reference-Cited by-同舟云学术

Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2− Breast Cancer

Published:2017-10 Issue:5 Volume:40 Page:490-497
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Wright Jean L.,Saigal Kunal,Reis Isildinha M.,Zhao Wei,Takita Cristiane,Ambros Tadeu,Saeed Ali M.,Sujoy Victoria,Hurley Judith

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference23 articles.

1. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27;Rastogi;J Clin Oncol,2008

2. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy;Huang;J Clin Oncol,2004

3. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27;Mamounas;J Clin Oncol,2012

4. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials;Fisher;Lancet,2004

5. Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer;Colleoni;J Clin Oncol,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016);Cancer Medicine;2024-06

2. The Challenges of Lobular Carcinomas from a Surgeon’s Point of View;Clinical Breast Cancer;2024-06

3. Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?;Breast Cancer Research and Treatment;2024-01-24

4. Neoadjuvant Endocrine Therapy Compared to Neoadjuvant Chemotherapy in Node‐Positive HR+, HER2− Breast Cancer (Nodal pCR and the Rate of ALND): A Systematic Review and Meta‐Analysis;The Breast Journal;2024-01

5. Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives;International Journal of Molecular Sciences;2020-05-16